- IN₹1.30tn
- IN₹1.33tn
- IN₹68.13bn
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
India's Laurus Labs closes lower on fifth straight qtrly profit drop
India's Glenmark Life Sciences posts lower Q4 profit as Red Sea crisis hurts API business
Brief: Laurus Labs March-Quarter Consol Net Profit Falls
Brief: Laurus Labs Says USFDA Completes Inspection Of Facilities At Anakapalli
India's Syngene, Neuland Labs rise as Goldman sets Street-high PTs
India's Laurus Labs hits near 1-1/2 year high
India's Laurus Labs slides as profit falls for fourth straight qtr
Brief: Laurus Labs Dec-Quarter Consol Net Profit Falls
India's Laurus Labs slides after facility gets US FDA observations
Brief: Laurus Labs Says Unit Underwent Us FDA Inspection For Manufacturing Facility In Parawada, Andhra Pradesh
US regulators inspect Dr Reddy's, other Indian pharma majors (updated)
India's Laurus Labs could see decline in earnings, analysts say
Brief: India's Laurus Labs Sept-Quarter Consol Net Profit Falls
India's Laurus Labs falls after brokerage flags weakness in core business
Brief: Laurus Labs To Acquire Of 37,641 Shares Of Laurus Bio For 716 Million Rupees
India's Divi's Labs Q1 profit slumps on drug pricing pressures
India's Laurus Labs "testing patience" after Q1 profit slump - Kotak
Brief: India's Laurus Labs June-Quarter Consol Net Profit Falls